Featured News
AMPEL BioSolutions’ Precision Medicine Breakthrough Predicts Drug Options with RNA Analytics & Machine Learning
AMPEL on Bloomberg Markets
Lupus, coronary artery disease share genetic risk factors; data may lead to early testing
Local company unveils blood test to find treatments for chronic pain
Local company unveils blood test to find treatments for chronic pain
AMPEL BioSolutions Enters MDx Market With Lupus, Dermatology Gene Expression Assays
Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee
COMPANY NEWS
Potential Employers Descend on Grounds During Annual Career Fair
CLICK TO VIEW ORIGINAL ARTICLE > by Caroline Newman, news@virginia.edu On Wednesday and Thursday, University of Virginia students donned their professional best and headed to Newcomb Hall for the annual Fall Job and Internship Fair, where they met with recruiters...
Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee
Virginia Catalyst Awards $2 Million in Grants to Support Life Sciences in the Commonwealth. Four collaborative projects involving Virginia research universities and industry partners selected to address major unmet healthcare needs, drive job creation and capital formation in Virginia.
Virginia Catalyst Awards $2 Million in Grants to Support Life Sciences in the Commonwealth
The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2 million in grants to four life and bioscience projects in the Commonwealth of Virginia, pending execution of the grant agreements.
Virginia Catalyst announces Grant Round 14 awarded projects
The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2 million in grants to four life and bioscience projects in the Commonwealth of Virginia, pending execution of the grant agreements.